Advances in oncolytic adenovirus therapy for pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer letters"
DOI: 10.1016/j.canlet.2018.07.006
Abstract: Survival rates for pancreatic cancer patients have remained unchanged for the last four decades. The most aggressive, and most common, type of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), which has the lowest 5-year survival… read more here.
Keywords: adenovirus therapy; pancreatic cancer; clinical trials; oncolytic adenovirus ... See more keywords